Genizon BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Genizon BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                         Genizon BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals and
                                                   Alliances Profile
       Reference Code: GDPH81751D                                                                                                            Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Genizon BioSciences, Inc. (Genizon) is involved in the genetic biomarker discovery.
                                                                                                              Genizon BioSciences, Inc., Pharmaceuticals &
      The company discovers genes and biomarkers in common diseases using genome-
                                                                                                              Healthcare, Key Facts
      wide association studies (GWAS). The services offered by the company include
      SNP genotyping, genetic analysis, gene expression, and pharmacogenomics                                  Web Address                      www.genizon.com
      services. The company focuses on genome-wide association studies for rheumatoid
                                                                                                               Revenue (US$ million)                           NA
      arthritis, Alzheimer’s disease, and coronary heart disease and its precursors,
      obesity, type II diabetes, dyslipidemia and hypertension. Genizon out-licensed some                      Number of Employees                                     94
      of its therapeutic and diagnostic rights to GeneMaps for Crohn’s disease and                             GlobalData
      endometriosis and Alzheimer’s disease to Pfizer.

      Financial Deals Landscape
        Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals                    Genizon BioSciences, Inc., Pharmaceuticals & Healthcare,
        by Type, 2007 to YTD 2013                                                         Deals By Year, 2007 to YTD 2013


                                                                                                                          2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                 1
                                                                                                          1


                                                                                                                                    0    0      0        0         0
                                                                                                          0
                                                                                                               2007      2008   2009    2010   2011     2012   YTD
                                                                                                                                                               2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Genizon BioSciences, Inc., Pharmaceuticals & Healthcare,                         Genizon BioSciences, Inc., Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013


                         3                                                                                           2
          No. of Deals




                                                                                           No. of Deals




                               3                                                                          2
                         2
                                        1                                                                                       1        1          1          1
                         1                                                                                1
                                                 0         0         0
                         0
                             North    Europe    Asia-    Middle   South                                   0
                             Americ            Pacific    East     and                                          Central Cardiov Dermat          Immun Metabol
                               a                          and     Central                                       Nervou ascular ology             ology    ic
                                                         Africa   Americ                                          s                                    Disorde
                                                                    a                                           System                                    rs



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Genizon BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals                                                                               Reference Code: GDPH81751D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................................ 3
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................ 5
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................................... 6
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013.......................................... 7
       Genizon BioSciences, Inc., Medical Devices Deals, 2007 to YTD 2013 ............................................................................................ 8
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ..................................................... 9
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deal Details ........................................................................................ 10
          Venture Financing......................................................................................................................................................................... 10
             Genizon BioSciences Secures $30.93 Million In Series E Financing Round............................................................................. 10
             Genizon BioSciences Secures $8 Million In Series D Equity Financing .................................................................................... 11
          Partnerships.................................................................................................................................................................................. 12
             Genizon BioSciences Enters Into Licensing And Collaboration Agreement With Pfizer ............................................................ 12
             Genizon BioSciences Enters Into Research Agreement With London Genetics And University College London ..................... 13
       Genizon BioSciences, Inc. - Key Competitors .................................................................................................................................. 14
       Key Employees ................................................................................................................................................................................ 15
       Locations And Subsidiaries .............................................................................................................................................................. 16
          Head Office ................................................................................................................................................................................... 16
       Appendix .......................................................................................................................................................................................... 17
          Methodology ................................................................................................................................................................................. 17
          About GlobalData ......................................................................................................................................................................... 17
          Contact Us .................................................................................................................................................................................... 17
          Disclaimer ..................................................................................................................................................................................... 17




Genizon BioSciences, Inc. - Pharmaceuticals & Healthcare - Deals                                                                                                   Reference Code: GDPH81751D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Key Facts.............................................................................................. 1
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................................ 1
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................................... 1
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013.......................................... 1
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................................ 4
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................ 5
       Genizon BioSciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................................... 6
       Genizon BioSciences, Inc., Deals By Therapy Area, 2007 to YTD 2013 ............................................................................................ 7
       Genizon BioSciences, Inc., Medical Devices Deals, 2007 to YTD 2013 ...............................................................
				
DOCUMENT INFO
Description: Genizon BioSciences, Inc. (Genizon) is involved in the genetic biomarker discovery. The company discovers genes and biomarkers in common diseases using genome-wide association studies (GWAS). The services offered by the company include SNP genotyping, genetic analysis, gene expression, and pharmacogenomics services. The company focuses on genome-wide association studies for rheumatoid arthritis, Alzheimer’s disease, and coronary heart disease and its precursors, obesity, type II diabetes, dyslipidemia and hypertension. Genizon out-licensed some of its therapeutic and diagnostic rights to GeneMaps for Crohn’s disease and endometriosis and Alzheimer’s disease to Pfizer. GeneMaps are also generated from GWAS in schizophrenia, psoriasis and longevity. Also, the company holds licensing partnership with Genentech. The company signed an agreement with London Genetics Ltd through which both the companies will collaborate to replicate discoveries generated by Genizon in a genome-wide association study of schizophrenia. Recently, Genizon partnered with Speid & Associates to increase success rates of new drug compounds with the use of Genizon's proprietary genetic platform. Genizon BioSciences, Inc. is headquartered in Quebec, Canada.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.